Lacosamide: a Study of Exposures Reported to US Poison Centers over a 9-Year Period.

Background: Lacosamide (Vimpat®) is an anticonvulsant used to treat partial-onset seizures. Little is known about the characteristics and outcomes of patients exposed to lacosamide.

Objective: To characterize lacosamide exposures reported to US poison centers with regard to patient demographics, clinical effects, and outcomes.